These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


766 related items for PubMed ID: 20496367

  • 1. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F, Gambini C, Gregorio A, Mosconi M, Reverberi D, Gattorno M, Casazza S, Uccelli A, Moretta L, Martini A, Traggiai E.
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [Abstract] [Full Text] [Related]

  • 2. Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice.
    Zhang Y, Saha S, Rosenfeld G, Gonzalez J, Pepeljugoski KP, Peeva E.
    J Rheumatol; 2010 Aug 01; 37(8):1646-57. PubMed ID: 20551107
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.
    Traggiai E, Volpi S, Schena F, Gattorno M, Ferlito F, Moretta L, Martini A.
    Stem Cells; 2008 Feb 01; 26(2):562-9. PubMed ID: 18024418
    [Abstract] [Full Text] [Related]

  • 4. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, Pistoia V, Martin I, Tyndall A.
    Rheumatology (Oxford); 2007 Mar 01; 46(3):403-8. PubMed ID: 16920750
    [Abstract] [Full Text] [Related]

  • 5. Identical, similar or different? Learning about immunomodulatory function of mesenchymal stem cells isolated from various mouse tissues: bone marrow, spleen, thymus and aorta wall.
    Hegyi B, Sági B, Kovács J, Kiss J, Urbán VS, Mészáros G, Monostori E, Uher F.
    Int Immunol; 2010 Jul 01; 22(7):551-9. PubMed ID: 20497958
    [Abstract] [Full Text] [Related]

  • 6. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb 01; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Placenta-derived MSCs are partially immunogenic and less immunomodulatory than bone marrow-derived MSCs.
    Fazekasova H, Lechler R, Langford K, Lombardi G.
    J Tissue Eng Regen Med; 2011 Oct 01; 5(9):684-94. PubMed ID: 21953866
    [Abstract] [Full Text] [Related]

  • 10. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
    Zhao L, Li G, Chan KM, Wang Y, Tang PF.
    Calcif Tissue Int; 2009 Jan 01; 84(1):56-64. PubMed ID: 19052794
    [Abstract] [Full Text] [Related]

  • 11. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC, Martin D, Zhang K, Hudkins KL, Alpers CE, Clark EA, Elkon KB.
    Arthritis Rheum; 2009 Jun 01; 60(6):1775-84. PubMed ID: 19479860
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
    Pau E, Chang NH, Loh C, Lajoie G, Wither JE.
    Clin Immunol; 2011 May 01; 139(2):215-27. PubMed ID: 21414847
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
    Xu G, Zhang L, Ren G, Yuan Z, Zhang Y, Zhao RC, Shi Y.
    Cell Res; 2007 Mar 01; 17(3):240-8. PubMed ID: 17325691
    [Abstract] [Full Text] [Related]

  • 16. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J, Farge D, Braccini A, Lecourt S, Scherberich A, Foïs E, Verrecchia F, Daikeler T, Gluckman E, Tyndall A, Bocelli-Tyndall C.
    Ann Rheum Dis; 2008 Apr 01; 67(4):443-9. PubMed ID: 17526552
    [Abstract] [Full Text] [Related]

  • 17. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI, Taraban VY, Seledtsova GV, Samarin DM, Avdeev IV, Senyukov VV, Kozlov VA.
    Cell Immunol; 1997 Nov 25; 182(1):12-9. PubMed ID: 9427805
    [Abstract] [Full Text] [Related]

  • 18. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation.
    Choi EW, Shin IS, Park SY, Park JH, Kim JS, Yoon EJ, Kang SK, Ra JC, Hong SH.
    Arthritis Rheum; 2012 Jan 25; 64(1):243-53. PubMed ID: 21904997
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov 25; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
    Yañez R, Oviedo A, Aldea M, Bueren JA, Lamana ML.
    Exp Cell Res; 2010 Nov 15; 316(19):3109-23. PubMed ID: 20804749
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 39.